Mycophenolate mofetil and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include chronic kidney disease among females and pancytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Gaviscon. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

On Jul, 06, 2026

30 people who take Mycophenolate mofetil and Gaviscon together, and have interactions are studied.

Mycophenolate mofetil and Gaviscon drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Gaviscon, by gender? *:

female:

Chronic kidney disease
Sepsis (a severe blood infection that can lead to organ failure and death)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Haemolytic anaemia (anaemia due to haemolysis)
Hypotension (abnormally low blood pressure)
Kidney transplant rejection
Renal failure (kidney dysfunction)
Septic shock (shock due to blood infection)
Somnolence (a state of near-sleep, a strong desire for sleep)
Thrombocytopenia (decrease of platelets in blood)

male:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Fluid retention (an abnormal accumulation of fluid in the blood)
Nausea (feeling of having an urge to vomit)
Pemphigoid (tense blisters on the skin)
Productive cough
Weight decreased
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Mycophenolate Mofetil and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Confusional state
Cellulitis (infection under the skin)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Chronic kidney disease
Erythrodermic psoriasis (generalized redness of the skin)
Haemolytic anaemia (anaemia due to haemolysis)
Infection
Psoriasis (immune-mediated disease that affects the skin)

50-59:

Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)

60+:

Fluid retention (an abnormal accumulation of fluid in the blood)
Pemphigoid (tense blisters on the skin)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Kidney transplant rejection
Renal failure (kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Somnolence (a state of near-sleep, a strong desire for sleep)

What are the existing conditions these people have? *

High Blood Pressure: 22 people, 73.33%
Pain: 18 people, 60.00%
Fungal Infection: 18 people, 60.00%
Diarrhea: 18 people, 60.00%
Cellulitis (infection under the skin): 18 people, 60.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 17 people, 56.67%
Fever: 15 people, 50.00%
Abdominal Pain: 13 people, 43.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 10.00%
Stress And Anxiety: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously